Altered expression of ezrin, E-Cadherin and β-Catenin in cervical neoplasia

Neoplasma

Volumn 60, Issue 1, 2013, Pages 56-61

  Auvinen, E ^a,b   Carpen, O ^c   Korpela, T ^c   Ronty, M ^b   Vaheri, A ^a   Tarkkanen, J ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

CIN; Ezrin; HPV; Papillomavirus

Indexed keywords

BETA CATENIN; EZRIN; UVOMORULIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TUMOR MARKER; VIRUS DNA;

ADENOCARCINOMA; ARTICLE; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL STRUCTURE; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; RISK; UTERINE CERVIX CANCER; CANCER GRADING; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PAPILLOMA VIRUS; PATHOLOGY; PROGNOSIS; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

ADENOCARCINOMA; BETA CATENIN; CADHERINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYTOSKELETAL PROTEINS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM GRADING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84875272393     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_008     Document Type: Article

References (38)

1. MELNIKOW J, NUOVO J, WILLAN AR, CHAN BKS, HOWELL LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 92: 727-735. http://dx.doi.org/10.1016/S0029-7844(98)00245-2
2. KAMB A, GRUIS NA, WEAVER-FELDHAUS J, LIU Q, HARSHMAN K, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440. http://dx.doi.org/10.1126/science.8153634
3. KLAES R, FRIEDRICH T, SPITKOVSKI D, RIDDER R, RUDY W, et al. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284. http://dx.doi.org/10.1002/ijc.1174
4. GOULD KL, BRETSCHER A, ESCH FS, HUNTER T. cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J 1989; 8: 4133-4142.
5. TURUNEN O, WINQVIST R, PAKKANEN R, GRZESCHIK KH, WAHLSTROM T, et al. Cytovillin, a microvillar Mr 75, 000 protein. J Biol Chem 1989; 264: 16727-16732.
6. VAHERI A, CARPEN O, HEISKA L, HELANDER TS, JAASKELAINEN J, et al. The ezrin protein family: membranecytoskeleton interactions and disease associations. Curr Opin Cell Biol 1997; 9: 659-666. http://dx.doi.org/10.1016/S0955-0674(97)80119-6
7. KAUL SC, MITSUI Y, KOMATSU Y, REDDEL RR, WADHWA R. A highly expressed 81 kDa protein in immortalized mouse fibroblast: its proliferative function and identity with ezrin. Oncogene 1996; 13: 1231-1237.
8. AKISAWA N, NISHIMORI I, IWAMURA T, ONISHI S, HOLLINGSWORTH MA. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Comm 1999; 258: 395-400. http://dx.doi.org/10.1006/bbrc.1999.0653
9. KHANNA C, KHAN J, NGUYEN P, PREHN J, CAYLOR J, et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001; 61: 3750-3759.
10. SHEN ZY, XU LY, CHEN MH, LI EM, LI JT, et al. Upregulated expression of ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J Gastroenterol 2003; 9: 1182-1186.
11. KHANNA C, WAN X, BOSE S, CASSADAY R, OLOMU O, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nature Med 2004; 10: 182-186. http://dx.doi.org/10.1038/nm982
12. YU Y, KHAN J, KHANNA C, HELMAN L, MELTZER PS, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nature Med 2004; 10: 175-181. http://dx.doi.org/10.1038/nm966
13. HEISKA L, MELIKOVA M, ZHAO F, SAOTOME I, MCCLATCHEY AI, et al. Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment. Oncogene 2011; 30: 4953-4962. http://dx.doi.org/10.1038/onc.2011.207
14. AUVINEN E, KIVI N, VAHERI A. Regulation of ezrin localization by Rac1 in epithelial cells. Exp Cell Res 2007; 313: 824-833. http://dx.doi.org/10.1016/j.yexcr.2006.12.002
15. GRECO D, KIVI N, QIAN K, LEIVONEN SK, AUVINEN P, et al. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS ONE 2011; 6(7): e21646. http://dx.doi.org/10.1371/journal.pone.0021646
16. YU Y, DAVICIONI E, TRICHE TJ, MERLINO G. The homeoprotein Six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res 2006; 66: 1982-1999. http://dx.doi.org/10.1158/0008-5472.CAN-05-2360
17. WAN F, MIAO X, QURAISHI I, KENNEDY V, CREEK KE, et al. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer 2008; 123: 32-40. http://dx.doi.org/10.1002/ijc.23463
18. HIROHASHI S, KANAI Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 575-581. http://dx.doi.org/10.1111/j.1349-7006.2003.tb01485.x
19. CARICO E, ATLANTE M, BUCCI B, NOFRONI I, VECCHIONE A. E-cadherin and α-catenin expression during tumor progression of cervical carcinoma. Gynecol Oncol 2001; 80: 156-161. http://dx.doi.org/10.1006/gyno.2000.6035
20. WILDING J, VOUSDEN KH, SOUTTER WP, MCCREA PD, DEL BUONO R, et al. E-cadherin transfection downregulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res 1996; 56: 5285-5292.
21. BOHLING T, TURUNEN O, JAASKELAINEN J, CARPEN O, SAINIO M, et al. Ezrin expression in stromal cells of capillary hemangioblastoma-an immunohistochemical survey of brain tumors. Am J Pathol 1996; 148: 367-373.
22. LUGINI L, LOZUPONE F, MATARRESE P, FUNARO C, LUCIANI F, et al. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest 2003; 83: 1555-1567. http://dx.doi.org/10.1097/01.LAB.0000098425.03006.42
23. LEONARD P, SHARP T, HENDERSON S, HEWITT D, PRINGLE J, et al. Gene expression array profile of human osteosarcoma. Br J Cancer 2003; 89: 2284-2288. http://dx.doi.org/10.1038/sj.bjc.6601389
24. MAKITIE T, CARPEN O, VAHERI A, KIVELA T. Ezrin as a prognostic factor and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophth Vis Sci 2001; 42: 2442-2449.
25. ILMONEN S, VAHERI A, ASKO-SELJAVAARA S, CARPEN O. Ezrin in primary cutaneous melanoma. Mod Pathol 2005; 18: 503-510. http://dx.doi.org/10.1038/modpathol.3800300
26. CHEN Z, FADIEL A, FENG Y, OHTANI K, RUTHERFORD T, et al. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1 and epidermal growth factor. Cancer 2001; 92: 3068-3075. http://dx.doi.org/10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5
27. NESTL A, VON STEIN OD, ZATLOUKAL K, THIES W-G, HERRLICH P, et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 2001; 61: 1569-1577.
28. CHIANG Y, CHOU CY, HSU KF, HUANG YF, SHEN MR. EGF upregulates Na+/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness. J Cell Physiol 2008; 214: 810-819. http://dx.doi.org/10.1002/jcp.21277
29. RODRIGUEZ-SASTRE MA, GONZALEZ-MAYA L, DELGADO R, LIZANO M, TSUBAKI G, et al. Abnormal distribution of E-cadherin and β-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol 2005; 97: 330-336. http://dx.doi.org/10.1016/j.ygyno.2004.12.062
30. KAPLANIS K, KIZIRIDOU A, LIBERIS V, DESTOUNI C, GALAZIOS G. E-cadherin expression during progression of squamous intraepithelial lesions in the uterine cervix. Eur J Gynaecol Oncol 2005; 26: 608-610.
31. VAN DE PUTTE G, KRISTENSEN GB, BAEKELANDT M, LIE AK, HOLM R. E-cadherin and catenins in early squamous cervical carcinoma. Gynecol Oncol 2004; 94: 521-527. http://dx.doi.org/10.1016/j.ygyno.2004.05.046
32. DE BOER CJ, VAN DORST E, VAN KRIEKEN H, JANSENVAN RHIJN CM, WARNAAR SO, et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol 1999; 155: 505-515. http://dx.doi.org/10.1016/S0002-9440(10)65146-2
33. FALEIRO-RODRIGUES C, LOPES C. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Pathobiol 2004; 71: 329-336. http://dx.doi.org/10.1159/000081729
34. MATTHEWS K, LEONG CM, BAXTER L, INGLIS E, YUN K, et al. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J Virol 2003; 77: 8378-8385. http://dx.doi.org/10.1128/JVI.77.15.8378-8385.2003
35. HISCOX S, JIANG WG. Ezrin regulates cell-cell and cellmatrix adhesion, a possible role with E-cadherin/β-catenin. J Cell Sci 1999; 112: 3081-3090.
36. MANI SA, GUO W, LIAO MJ, EATON EN, AYYANAN A, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715. http://dx.doi.org/10.1016/j.cell.2008.03.027
37. CUZICK J, SZAREWSKI A, CUBIE H, HULMAN G, KITCHENER H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871-1876. http://dx.doi.org/10.1016/S0140-6736(03)14955-0
38. MIDDLETON K, PEH W, SOUTHERN S, GRIFFIN H, SOTLAR K, et al. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 2003; 77: 10186-10201. http://dx.doi.org/10.1128/JVI.77.19.10186-10201.2003